OKYO Research Development from 2010 to 2026
| OKYO Stock | USD 1.73 0.00 0.00% |
Research Development | First Reported 2017-12-31 | Previous Quarter 38.4 K | Current Value -44 K | Quarterly Volatility 478.1 K |
Check OKYO Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OKYO Pharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.2 K, Interest Expense of 1.1 M or Selling And Marketing Expenses of 20.2 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 2.1 or Days Sales Outstanding of 0.0. OKYO financial statements analysis is a perfect complement when working with OKYO Pharma Valuation or Volatility modules.
OKYO | Research Development | Build AI portfolio with OKYO Stock |
Evaluating OKYO Pharma's Research Development across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into OKYO Pharma Ltd's fundamental strength.
Latest OKYO Pharma's Research Development Growth Pattern
Below is the plot of the Research Development of OKYO Pharma Ltd over the last few years. It is OKYO Pharma's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in OKYO Pharma's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
OKYO Research Development Regression Statistics
| Arithmetic Mean | 3,106,649 | |
| Geometric Mean | 2,526,957 | |
| Coefficient Of Variation | 59.45 | |
| Mean Deviation | 1,032,312 | |
| Median | 3,044,000 | |
| Standard Deviation | 1,846,842 | |
| Sample Variance | 3.4T | |
| Range | 7.9M | |
| R-Value | 0.15 | |
| Mean Square Error | 3.6T | |
| R-Squared | 0.02 | |
| Significance | 0.56 | |
| Slope | 55,898 | |
| Total Sum of Squares | 54.6T |
OKYO Research Development History
About OKYO Pharma Financial Statements
OKYO Pharma investors utilize fundamental indicators, such as Research Development, to predict how OKYO Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Research Development | 2.6 M | 3.5 M |
Pair Trading with OKYO Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OKYO Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OKYO Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against OKYO Stock
The ability to find closely correlated positions to OKYO Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OKYO Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OKYO Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OKYO Pharma Ltd to buy it.
The correlation of OKYO Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OKYO Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OKYO Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OKYO Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of OKYO Pharma Correlation against competitors. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Will Biotechnology sector continue expanding? Could OKYO diversify its offerings? Factors like these will boost the valuation of OKYO Pharma. Anticipated expansion of OKYO directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every OKYO Pharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of OKYO Pharma is measured differently than its book value, which is the value of OKYO that is recorded on the company's balance sheet. Investors also form their own opinion of OKYO Pharma's value that differs from its market value or its book value, called intrinsic value, which is OKYO Pharma's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because OKYO Pharma's market value can be influenced by many factors that don't directly affect OKYO Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between OKYO Pharma's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding OKYO Pharma should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, OKYO Pharma's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.